Thank you for the question.
We are investing significantly in looking at further options. We have Paxlovid, as you mentioned, which is an important treatment that is available right now around the world. Of course, we need to continue the research. We need to look at other studies to see what the impact of Paxlovid will be on long COVID.
As we're doing this, we are also continuing some research to see if there is anything else that could be used eventually to address the long COVID issues.